AU2008353492A1 - Processes for the preparation of benzo-fused dioxin derivatives - Google Patents

Processes for the preparation of benzo-fused dioxin derivatives Download PDF

Info

Publication number
AU2008353492A1
AU2008353492A1 AU2008353492A AU2008353492A AU2008353492A1 AU 2008353492 A1 AU2008353492 A1 AU 2008353492A1 AU 2008353492 A AU2008353492 A AU 2008353492A AU 2008353492 A AU2008353492 A AU 2008353492A AU 2008353492 A1 AU2008353492 A1 AU 2008353492A1
Authority
AU
Australia
Prior art keywords
formula
compound
yield
group
reacting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2008353492A
Other languages
English (en)
Inventor
Scott A. Ballentine
Laura Reany
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of AU2008353492A1 publication Critical patent/AU2008353492A1/en
Assigned to JANSSEN PHARMACEUTICA, N.V. reassignment JANSSEN PHARMACEUTICA, N.V. Amend patent request/document other than specification (104) Assignors: JASSEN PHARMACEUTICA, N.V.
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
AU2008353492A 2008-03-26 2008-03-26 Processes for the preparation of benzo-fused dioxin derivatives Abandoned AU2008353492A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2008/058247 WO2009120192A2 (en) 2008-03-26 2008-03-26 Process for the preparation of benzo-fused heteroaryl derivatives

Publications (1)

Publication Number Publication Date
AU2008353492A1 true AU2008353492A1 (en) 2009-10-01

Family

ID=40351717

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2008353492A Abandoned AU2008353492A1 (en) 2008-03-26 2008-03-26 Processes for the preparation of benzo-fused dioxin derivatives

Country Status (13)

Country Link
EP (1) EP2280951A2 (es)
JP (1) JP2011517448A (es)
KR (1) KR20100126536A (es)
CN (1) CN101981023A (es)
AU (1) AU2008353492A1 (es)
BR (1) BRPI0822396A2 (es)
CA (1) CA2719402A1 (es)
EA (1) EA201071121A1 (es)
EC (1) ECSP10010498A (es)
IL (1) IL208223A0 (es)
MX (1) MX2010010597A (es)
WO (1) WO2009120192A2 (es)
ZA (1) ZA201007610B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY147767A (en) 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
AU2006249577A1 (en) 2005-05-20 2006-11-30 Janssen Pharmaceutica N.V. Process for preparation of sulfamide derivatives
US8691867B2 (en) 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
US8497298B2 (en) 2005-12-19 2013-07-30 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
US8937096B2 (en) 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
EP2026790A2 (en) 2006-05-19 2009-02-25 Janssen Pharmaceutica, N.V. Co-therapy for the treatment of epilepsy and related disorders
BRPI0915890A2 (pt) 2008-06-23 2015-11-03 Janssen Pharmaceutica Nv forma cristalina de (2s)-(-)-n-(6-cloro-2,3-di-hidro-benzo[1,4]dioxin-2-ilmetil)-sulfamida
US8815939B2 (en) 2008-07-22 2014-08-26 Janssen Pharmaceutica Nv Substituted sulfamide derivatives
AU2012314317A1 (en) * 2011-09-29 2014-04-03 Janssen Pharmaceutica Nv Improved process for the preparation of sulfamide derivatives
JP2014528953A (ja) * 2011-09-29 2014-10-30 ヤンセン ファーマシューティカ エヌ．ベー． スルファミド誘導体の調製プロセス

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5120758A (en) * 1991-02-08 1992-06-09 Ciba-Geigy Corporation Certain benzodioxole, benzodioxane and benzodioxepin derivatives useful as 5-lipoxygenase inhibitors
MY147767A (en) * 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders

Also Published As

Publication number Publication date
WO2009120192A2 (en) 2009-10-01
WO2009120192A3 (en) 2010-01-21
ZA201007610B (en) 2012-04-25
JP2011517448A (ja) 2011-06-09
MX2010010597A (es) 2010-10-25
KR20100126536A (ko) 2010-12-01
ECSP10010498A (es) 2010-10-30
BRPI0822396A2 (pt) 2019-09-24
EP2280951A2 (en) 2011-02-09
CN101981023A (zh) 2011-02-23
IL208223A0 (en) 2010-12-30
CA2719402A1 (en) 2009-10-01
EA201071121A1 (ru) 2011-04-29

Similar Documents

Publication Publication Date Title
US20090247618A1 (en) Process for preparation of benzo-fused heteroaryl derivatives
AU2008353492A1 (en) Processes for the preparation of benzo-fused dioxin derivatives
US20090247617A1 (en) Process for the preparation of benzo-fused heteroaryl sulfamates
CA2570614C (en) Sulfamate and sulfamide derivatives for the treatment of epilepsy and related disorders
JP5416740B2 (ja) てんかんおよび関連疾患を治療するためのスルファメートおよびスルファミド誘導体
US20090182141A1 (en) Process for the preparation of sulfamide derivatives
WO2009120191A1 (en) Process for the preparation of benzo-fused heteroaryl sulfamates and crystalline form of n- ( ( (2s) -6-chloro-2,3-dihydro-l,4-benzodioxin-2-yl) methyl-sulfamide
FI76331B (fi) Foerfarande foer framstaellning av terapeutiskt aktiva substituerade 4-aminometylenkromaner och kromener.
EA015962B1 (ru) Способ лечения злоупотребления алкоголем и аддикции
EP0446921B1 (en) Optically active alkylene-dioxybenzene derivatives and their use in therapy
AU2012316279A1 (en) Process for the preparation of sulfamide derivatives
KR101198831B1 (ko) 간질 및 연관된 질병의 치료용 설파메이트 및 설파미드유도체
KR20070021316A (ko) 간질 및 연관된 질병의 치료용 설파메이트 및 설파미드유도체

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application